To address what kind of obesity-associated factors reduced the anticancer efficacy of AdipoRon, we examined the effect of glucose, insulin, IGF-1 and leptin on the survival of AdipoRon-treated Panc02-Luc-ZsGreen cells in vitro. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.